Clover Health Investments, Corp. - 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by Clover Health Investments, Corp. (CLOV) on April 22, 2025, covering events occurring on April 21, 2025. The Company is a remote-first organization with no physical headquarters, operating primarily in the healthcare sector.
Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The report focuses exclusively on corporate governance changes.
Material Changes
- Board Departure: Lee A. Shapiro, a Director and Chairman of the Audit and Nominating/Corporate Governance Committees, will not stand for re-election due to new responsibilities as Chairman of the American Heart Association.
- Effective Date: Mr. Shapiro's departure is effective June 10, 2025, following the Annual Meeting of Shareholders.
- Committee Leadership Changes: Effective June 10, 2025, Thomas L. Tran will be appointed as the new Chairman of the Audit Committee and Chairman of the Nominating and Corporate Governance Committee.
- Board Composition: The Board will operate with one vacant seat following Mr. Shapiro's departure, though the authorized number of directors remains nine.
Guidance, Outlook, and Risks
The filing states that Mr. Shapiro's departure is not related to any disagreement with the Company regarding operations, policies, or practices. The Board intends to fill the vacancy as soon as practicable. No financial guidance, outlook, or new risk factors were disclosed in this report.
Key Investor Verification Points
- Confirm the timeline for the Board's appointment of a new director to fill the vacancy left by Lee A. Shapiro.
- Review the upcoming Annual Meeting of Shareholders scheduled for June 10, 2025, for details on the election of directors.
- Verify the background and qualifications of Thomas L. Tran in his expanded role leading the Audit and Nominating Committees.